Evolving treatment strategies for HER2-altered non-small-cell lung cancer: the rise of TKIs and ADCs.
Saved in:
| Title: | Evolving treatment strategies for HER2-altered non-small-cell lung cancer: the rise of TKIs and ADCs. |
|---|---|
| Authors: | Balli S; Department of Medical Oncology, Samsun City Hospital, Samsun, Türkiye., Basoglu T; Department of Medical Oncology, Memorial Göztepe Cancer Center, Istanbul, Türkiye., Ozdogan M; Department of Medical Oncology, Memorial Göztepe Cancer Center, Istanbul, Türkiye.; Department of Medical Oncology, Antalya Memorial Hospital, Antalya, Türkiye. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Mar 25; Vol. 16, pp. 1771869. Date of Electronic Publication: 2026 Mar 25 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
